Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//PSYCHOLOGY, EXPERIMENTAL | 1830502 |
493 | 3 | ADENOSINE//ADENOSINE RECEPTORS//LYSOPHOSPHATIDIC ACID | 23662 |
625 | 2 | ADENOSINE//ADENOSINE RECEPTORS//ADENOSINE A2A RECEPTOR | 14193 |
4842 | 1 | CD73//ADENOSINE RECEPTORS//ADENOSINE | 1743 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CD73 | authKW | 1004161 | 6% | 54% | 103 |
2 | ADENOSINE RECEPTORS | authKW | 523609 | 12% | 14% | 203 |
3 | ADENOSINE | authKW | 510724 | 24% | 7% | 418 |
4 | NEW ENGLAND INFLAMMAT TISSUE PROTECT | address | 347478 | 2% | 62% | 31 |
5 | MUCOSAL INFLAMMAT PROGRAM | address | 337422 | 3% | 33% | 56 |
6 | A3 ADENOSINE RECEPTOR | authKW | 240197 | 2% | 39% | 34 |
7 | CD39 | authKW | 227208 | 3% | 26% | 49 |
8 | IB MECA | authKW | 192845 | 1% | 67% | 16 |
9 | ADENOSINE A3 RECEPTOR | authKW | 109672 | 1% | 24% | 25 |
10 | ECTO 5 NUCLEOTIDASE | authKW | 104910 | 2% | 17% | 35 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Immunology | 3416 | 22% | 0% | 387 |
2 | Cell Biology | 1272 | 15% | 0% | 269 |
3 | Pharmacology & Pharmacy | 921 | 16% | 0% | 271 |
4 | Hematology | 646 | 7% | 0% | 115 |
5 | Oncology | 614 | 12% | 0% | 204 |
6 | Medicine, Research & Experimental | 573 | 8% | 0% | 138 |
7 | Physiology | 560 | 7% | 0% | 123 |
8 | Biochemistry & Molecular Biology | 232 | 14% | 0% | 244 |
9 | Peripheral Vascular Diseases | 226 | 4% | 0% | 71 |
10 | Rheumatology | 185 | 2% | 0% | 38 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | NEW ENGLAND INFLAMMAT TISSUE PROTECT | 347478 | 2% | 62% | 31 |
2 | MUCOSAL INFLAMMAT PROGRAM | 337422 | 3% | 33% | 56 |
3 | NAZL ECCELLENZA SVILUPPO METODOL INNOVAT STUD | 75333 | 0% | 83% | 5 |
4 | TUMOR CLIN IMMUNOL | 57855 | 0% | 80% | 4 |
5 | FELSENSTEIN MED CLIN TUMOR IMMUNOL | 48211 | 0% | 67% | 4 |
6 | DRUG PHARMACOL SCI | 44287 | 0% | 35% | 7 |
7 | IMMUNOBIOL CANC PROGRAM | 41062 | 1% | 11% | 21 |
8 | CANC INFANTIL RS | 36160 | 0% | 100% | 2 |
9 | GRP EXPT HEMATOL | 36160 | 0% | 100% | 2 |
10 | INFLAMMAT HYPOXIA | 36160 | 0% | 100% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PURINERGIC SIGNALLING | 85438 | 3% | 10% | 47 |
2 | JOURNAL OF IMMUNOLOGY | 3771 | 6% | 0% | 108 |
3 | DRUG DEVELOPMENT RESEARCH | 2645 | 1% | 1% | 21 |
4 | ONCOIMMUNOLOGY | 2590 | 1% | 1% | 13 |
5 | FASEB JOURNAL | 1833 | 2% | 0% | 32 |
6 | JOURNAL OF LEUKOCYTE BIOLOGY | 1549 | 1% | 0% | 25 |
7 | PHYSIOLOGICAL RESEARCH | 1450 | 1% | 1% | 15 |
8 | AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY | 1087 | 1% | 0% | 19 |
9 | MOLECULAR PHARMACOLOGY | 1019 | 1% | 0% | 24 |
10 | FRONTIERS IN IMMUNOLOGY | 930 | 1% | 0% | 14 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CD73 | 1004161 | 6% | 54% | 103 | Search CD73 | Search CD73 |
2 | ADENOSINE RECEPTORS | 523609 | 12% | 14% | 203 | Search ADENOSINE+RECEPTORS | Search ADENOSINE+RECEPTORS |
3 | ADENOSINE | 510724 | 24% | 7% | 418 | Search ADENOSINE | Search ADENOSINE |
4 | A3 ADENOSINE RECEPTOR | 240197 | 2% | 39% | 34 | Search A3+ADENOSINE+RECEPTOR | Search A3+ADENOSINE+RECEPTOR |
5 | CD39 | 227208 | 3% | 26% | 49 | Search CD39 | Search CD39 |
6 | IB MECA | 192845 | 1% | 67% | 16 | Search IB+MECA | Search IB+MECA |
7 | ADENOSINE A3 RECEPTOR | 109672 | 1% | 24% | 25 | Search ADENOSINE+A3+RECEPTOR | Search ADENOSINE+A3+RECEPTOR |
8 | ECTO 5 NUCLEOTIDASE | 104910 | 2% | 17% | 35 | Search ECTO+5+NUCLEOTIDASE | Search ECTO+5+NUCLEOTIDASE |
9 | ATL313 | 90401 | 0% | 100% | 5 | Search ATL313 | Search ATL313 |
10 | CF101 | 90401 | 0% | 100% | 5 | Search CF101 | Search CF101 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |